Semba, 2001 - Google Patents
The vitamin A and mortality paradigm: past, present, and futureSemba, 2001
View PDF- Document ID
- 1044361515336733169
- Author
- Semba R
- Publication year
- Publication venue
- Näringsforskning
External Links
Snippet
Vitamin A deficiency contributes to the morbidity and mortality from some infectious diseases. Empirical observations and trials from the early twentieth century led to the paradigm that improvement of vitamin A status could reduce morbidity and mortality among …
- 235000019155 vitamin A 0 title abstract description 87
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. cannabinols, methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A23B - A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU725308B2 (en) | Anti-stress composition | |
USRE38009E1 (en) | Zeaxanthin formulations for human ingestion | |
US6946451B2 (en) | Insulin secretion promoter | |
AU780120B2 (en) | Compositions normalizing circadian rhythm | |
Béhar et al. | Principles of treatment and prevention of severe protein malnutrition in children (kwashiorkor) | |
US5431925A (en) | Nutritive composition for prevention and therapy of infection diseases caused by immunosuppression | |
JPWO2007000985A1 (en) | Composition for preventing or treating hemoglobinuria or myoglobinuria | |
US20190246679A1 (en) | Fortified Micronutrient Food and Beverage Additive | |
JP2001002569A (en) | Composition for improving memory | |
MX2007003773A (en) | Compositions and methods for promoting weight gain and feed conversion. | |
JP2007223914A (en) | Oral administration formulation | |
JP2002255846A (en) | Oral composition | |
Semba | The vitamin A and mortality paradigm: past, present, and future | |
JP2018503605A (en) | 25-Hydroxyvitamin D and antioxidant / anti-inflammatory combination for human functional foods | |
EP3135281A1 (en) | Composition for preventing or improving peripheral neuropathy | |
Bauernfeind | Vitamin A: Technology and applications | |
WO2019107531A1 (en) | Composition for suppressing increase in or reducing blood lipids | |
US7691406B2 (en) | Zeaxanthin formulations for human ingestion | |
Nadimin et al. | Nutritional intervention based on moringa leaf flour to prevent stunting in first 1000 days of life (1000 HPK): Review articles | |
JP2002159279A (en) | Improving agent with ability to utilize oxygen | |
JPH06192104A (en) | Composition for curing and preventing infantile dysbolism | |
JP6912214B2 (en) | Red blood cell function improver | |
JP6734101B2 (en) | Heart rate recovery promoting composition | |
WO2001010424A2 (en) | Reducing cholesterol oxides using n-3-pufa and vitamin e | |
WO2011118468A1 (en) | Wake-time-extending agent |